Intraperitoneal infusion of homocysteine increases intimal hyperplasia in balloon-injured rat carotid arteries

Atherosclerosis

Volumn 160, Issue 1, 2002, Pages 103-114

  Chen, Changyi ^a   Surowiec, Scott M ^a   Morsy, Amro H ^a   Ma, Minhui ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell proliferation; Homocysteine; Intimal hyperplasia; Rat

Indexed keywords

BROXURIDINE; HOMOCYSTEINE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY RECONSTRUCTION; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS; RISK FACTOR; SMOOTH MUSCLE FIBER;

ANIMALS; BALLOON DILATATION; CAROTID ARTERY INJURIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOCYSTEINE; HYPERPLASIA; INFUSIONS, PARENTERAL; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA;

EID: 0036146184     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00573-1     Document Type: Article

References (68)

1. Disorders of transsulfuration: The metabolic and molecular basis of inherited disease
2. Vitamin status and intake as primary determinants of homocystinemia in an elderly population
3. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine metabolism
4. The metabolism of homocysteine: Pathways and regulation
5. Biochemistry and molecular genetics of cystathionine beta-synthase deficiency
6. The natural history of homocystinuria due to cystathionine beta-synthase deficiency
7. Homocysteine theory of arteriosclerosis
8. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease
9. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
10. Homocysteine: An independent risk factor for the failure of vascular intervention
11. Hyperhomocysteinaemia is a risk factor for vein graft stenosis
12. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis
13. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
14. Interrelation of hyperhomocyst(e)inemia, Factor V Leiden, and risk of future venous thromboembolism
15. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
16. Coronary atherosclerosis and interventions: Pathological sequences and restenosis
17. Pathophysiology of restenosis: Interaction of thrombosis, hyperplasia, and/or remodeling
18. Smooth muscle migration in atherosclerosis and restenosis
19. The biology of restenosis
20. Kinetics of cellular proliferation after arterial injury, I: Smooth muscle growth in the absence of endothelium
21. Oral administration of L-arginine reduces intimal hyperplasia in balloon-injured carotid arteies
22. Boundary layer infusion of heparin prevents thrombosis and reduces neointimal hyperplasia in venous PTFE grafts without systemic anticoagulation
23. Recombinant mitotoxin basic FGF saporin reduces venous intimal hyperplasia
24. Angiogensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
25. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1)
26. Mechanisms of stenosis after arterial injury
27. Arterial response to mechanical injury: Balloon catheter deendothelialization
28. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia
29. Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model
30. Renal uptake and excretion of homocysteine in rats with acute hyperhomocysteinemia
31. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metablism in the rat
32. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum
33. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models
34. Total homocysteine in plasma or serum: Methods and clinical applications
35. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
36. The pathogenesis of atherosclerosis: A perspective for the 1990s
37. Developmental mechanisms underlying pathology of arteries
38. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons
39. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
40. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells
41. In vitro and in vivo vascular actions of basic fibroblast growth factor (bFGF) in normotensive and spontaneously hypertensive rats
42. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: A possible role for hydrogen peroxide
43. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening
44. Endothelial regeneration. II. Restitution of endothelial continuity
45. Intimal healing: The pattern of reendothelialization and intimal thickening
46. Kinetics of cellular proliferation after arterial injury I. Smooth muscle growth in the absence of endothelium
47. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
48. Nitric oxide release accounts for the biological activity of endothelium-derived relaxation factor
49. Nitric oxide-generating vasodilators and 8-bromo-cGMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
50. Regulation of smooth muscle cell growth by endothelium-derived factors
51. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation
52. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
53. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not their heterozygous parents
54. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
55. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
56. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: Role for superoxide anions
57. Endothclial cell injury due to coppercatalyzed hydrogen peroxide generation from homocysteine
58. The oxidant stress of hyperhomocyst(e)inemia
59. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
60. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
61. The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective
62. Activation of Hageman factor by L-homocystine
63. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
64. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
65. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
66. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells
67. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells
68. Thiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages